APO RESEARCH · REPORT
Apomorphine Hydrochloride
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Product & engineering
Understand the product.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Selected research
Industry Research
Apomorphine Hydrochloride Industry Research Report 2026
Market perspective
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Scope
This report quantifies the global Apomorphine Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Apomorphine Hydrochloride Market by Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Apomorphine Hydrochloride Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Apomorphine Hydrochloride Segment by Application
Parkinson Disease
Erectile Dysfunction
Apomorphine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Apomorphine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
- Thinfilm
- Nasal Powder (Pipeline)
Applications
- Parkinson Disease
- Erectile Dysfunction
Companies covered
- Supernus Pharmaceuticals
- Britannia Pharmaceuticals STADA
- Ever Pharma
- Evolan Pharma AB (PharmSwed)
- Tianjin Tianwei Pharmaceutical
- Sunovion
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Apomorphine Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Apomorphine Hydrochloride Sales (2021-2032)
- 2.2.3 Global Apomorphine Hydrochloride Market Average Price (2021-2032)
- 2.3 Apomorphine Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Tablets
- 2.3.4 Thinfilm
- 2.3.5 Nasal Powder (Pipeline)
- 2.4 Apomorphine Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Parkinson Disease
- 2.4.3 Erectile Dysfunction
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Apomorphine Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Apomorphine Hydrochloride Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Apomorphine Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Apomorphine Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Apomorphine Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Apomorphine Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Apomorphine Hydrochloride, Established Date
- 3.9 Global Apomorphine Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Supernus Pharmaceuticals
- 4.1.1 Supernus Pharmaceuticals Company Information
- 4.1.2 Supernus Pharmaceuticals Business Overview
- 4.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
- 4.1.5 Supernus Pharmaceuticals Recent Developments
- 4.2 Britannia Pharmaceuticals STADA
- 4.2.1 Britannia Pharmaceuticals STADA Company Information
- 4.2.2 Britannia Pharmaceuticals STADA Business Overview
- 4.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
- 4.2.5 Britannia Pharmaceuticals STADA Recent Developments
- 4.3 Ever Pharma
- 4.3.1 Ever Pharma Company Information
- 4.3.2 Ever Pharma Business Overview
- 4.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
- 4.3.5 Ever Pharma Recent Developments
- 4.4 Evolan Pharma AB (PharmSwed)
- 4.4.1 Evolan Pharma AB (PharmSwed) Company Information
- 4.4.2 Evolan Pharma AB (PharmSwed) Business Overview
- 4.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
- 4.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
- 4.5 Tianjin Tianwei Pharmaceutical
- 4.5.1 Tianjin Tianwei Pharmaceutical Company Information
- 4.5.2 Tianjin Tianwei Pharmaceutical Business Overview
- 4.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
- 4.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
- 4.6 Sunovion
- 4.6.1 Sunovion Company Information
- 4.6.2 Sunovion Business Overview
- 4.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
- 4.6.5 Sunovion Recent Developments
5 Global Apomorphine Hydrochloride Market Scenario by Region
- 5.1 Global Apomorphine Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Apomorphine Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Apomorphine Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Apomorphine Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Apomorphine Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Apomorphine Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Apomorphine Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Apomorphine Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Apomorphine Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Apomorphine Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Apomorphine Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Apomorphine Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Apomorphine Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Apomorphine Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Apomorphine Hydrochloride Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Apomorphine Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Apomorphine Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Apomorphine Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Apomorphine Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Apomorphine Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Apomorphine Hydrochloride Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Apomorphine Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Apomorphine Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Apomorphine Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Apomorphine Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Apomorphine Hydrochloride Value Chain Analysis
- 8.1.1 Apomorphine Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Apomorphine Hydrochloride Production Mode & Process
- 8.2 Apomorphine Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Apomorphine Hydrochloride Distributors
- 8.2.3 Apomorphine Hydrochloride Customers
9 Global Apomorphine Hydrochloride Analyzing Market Dynamics
- 9.1 Apomorphine Hydrochloride Industry Trends
- 9.2 Apomorphine Hydrochloride Industry Drivers
- 9.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
- 9.4 Apomorphine Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst